Sacituzumab Govitecan Plus Bevacizumab in Metastatic TNBC
Sacituzumab Govitecan Plus Bevacizumab in Metastatic TNBC
Enrolling by invitation · NCT07359404 · Registry updated 2026-01-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Sacituzumab Govitecan Plus Bevacizumab in Metastatic TNBC | Advanced Breast Cancer | Enrolling by invitation | Phase 2 | 2026-01-22 | NCT07359404 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| YING FAN | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cancer hospital, Chinese Academy of Medical Sciences | Beijing | China | 12 |